Markets:

Overview

News

Currencies

International

Treasuries

Stoke Therapeutics, Inc. - Common Stock (NQ:STOK)

34.37 +3.39 (+10.94%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Stoke Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Crude Oil Moves Lower; TD SYNNEX Earnings Top Estimates ↗

March 26, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 80 points on Tuesday. The Dow traded up 0.21% to 39,397.20 while the NASDAQ rose 0.23% to 16,421.62. The S&P 500...

Via Benzinga

Topics Stocks

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 26, 2024

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 26, 2024

Via Benzinga

The Latest Analyst Ratings for Stoke Therapeutics ↗

July 31, 2023

Via Benzinga

Dow Gains 100 Points; McCormick Posts Upbeat Results ↗

March 26, 2024

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 100 points on Tuesday. The Dow traded up 0.25% to 39,413.30 while the NASDAQ rose 0.27% to 16,448.55. The S&P 500...

Via Benzinga

Topics Stocks

Nasdaq Gains Over 50 Points; US Durable Goods Orders Rise In February ↗

March 26, 2024

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Tuesday. The Dow traded up 0.08% to 39,346.40 while the NASDAQ rose 0.39% to 16,448.92. The S&P 500 also...

Via Benzinga

Topics Stocks

Stoke Therapeutics' Anti-Epilepsy Drug Candidate Shows Substantial, Sustained Reductions In Seizure Frequency In Pretreated Patients ↗

March 26, 2024

New data from Stoke Therapeutics' STK-001 studies reveal significant reductions in seizures and cognitive improvements in children with Dravet syndrome. STK-001 demonstrates promise as a well-tolerated...

Via Benzinga

Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today? ↗

March 26, 2024

NeuBase Therapeutics stock is down on Tuesday as NBSE investors react to details concerning an upcoming special shareholder meeting.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 26, 2024

Via Benzinga

Why Is Check-Cap (CHEK) Stock Up 44% Today? ↗

March 26, 2024

Check-Cap stock is up on Tuesday with heavy trading as CHEK investors react to news of a business combination with Nobul AI.

Via InvestorPlace

Tesla To $120? Here Are 10 Top Analyst Forecasts For Tuesday ↗

March 26, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket ↗

March 26, 2024

Shares of Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase 1/2a data supporting the potential for STK-001

Via Benzinga

Why Is Stoke Therapeutics (STOK) Stock Up 99% Today? ↗

March 26, 2024

Stoke Therapeutics stock is up on Tuesday as STOK shares see heavy trading alongside recent positive clinical trial data.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 26, 2024

It's time to dive into the biggest pre-market stock movers on Tuesday as we check out all of the hottest news moving shares this morning!

Via InvestorPlace

STOK Stock Earnings: Stoke Therapeutics Beats EPS, Misses Revenue for Q4 2023 ↗

March 25, 2024

STOK stock results show that Stoke Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 25, 2024

Via Benzinga

Stoke Therapeutics Stock Rockets On Phase 1/2a Data: Here's Why ↗

March 25, 2024

Stoke Therapeutics reported its fourth-quarter financial results and announced Phase 1/2a end of study data after the bell Monday. The company reported quarterly losses of 60 cents per share which beat...

Via Benzinga

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory ↗

February 25, 2024

Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Thursday ↗

September 21, 2023

During the session on Thursday, 461 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

September 26, 2023

On Tuesday, 386 stocks made new 52-week lows.

Via Benzinga

This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street ↗

August 16, 2023

This small-cap biotech might be a hidden gem.

Via The Motley Fool

Stocks That Hit 52-Week Lows On Thursday ↗

July 27, 2023

During Thursday, 56 stocks hit new 52-week lows.

Via Benzinga

Why Shares of Stoke Therapeutics Plummeted Tuesday ↗

July 25, 2023

The company's shares fell after it released early trial results on its lead therapy.

Via The Motley Fool

Crude Oil Up 1%; Verizon Earnings Beat Views ↗

July 25, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 0.28% to 35,510.96 while the NASDAQ rose 0.91% to 14,187.05....

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

July 26, 2023

Wednesday saw 59 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 25, 2023

Via Benzinga

Why Stoke Therapeutics Is Trading Lower Today? ↗

July 25, 2023

Stoke Therapeutics Inc (NASDAQ: STOK) shares are trading lower after the company released new safety & efficacy data from STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL...

Via Benzinga

Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 25, 2023

Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

July 25, 2023

On Tuesday, 56 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 25, 2023

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Stoke Therapeutics, Inc. - Common Stock (NQ:STOK)

Headline News about Stoke Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today